Developer docs
API playgroundTry for free, no card

Search company profiles

TMS Health Solutions

Full company profile

uuid0004g29

Namestring
TMS Health Solutions
Legal namestring
Mindful Health Solutions
Company typeenum
Private
Founded yearint
2007
Descriptiontext

TMS Health Solutions, operating under the DBA Mindful Health Solutions, is a private interventional psychiatry provider founded in 2007 and headquartered in San Francisco. The company delivers FDA-cleared, device- and medication-based treatments for treatment-resistant depression and other mood and anxiety disorders, with a portfolio comprising Transcranial Magnetic Stimulation (TMS, including standard, Accelerated, and the MindfulONE One-Day protocols), SPRAVATO (Esketamine) nasal spray therapy, Ketamine Infusion Therapy, psychiatric medication management, and California-based telepsychiatry. Reported clinical efficacy figures include approximately 63% effectiveness for TMS, 70% for SPRAVATO, 49% for Ketamine, and an overall 80% symptom-improvement rate across treated patients, with 100,000+ patients and 300,000+ interventional treatments administered cumulatively.

The company monetizes through recurring per-session and per-treatment-course billing under major commercial insurance plans, with self-pay options for uninsured services. Patient acquisition runs through a sales-led GTM combining direct-to-consumer channels (content marketing, social media on Facebook, Instagram, TikTok, YouTube, and LinkedIn, plus online insurance verification and self-scheduling tools), a healthcare provider referral program, and a 20-clinic physical footprint across California (15 clinics in the Sacramento, Bay Area, and Southern California regions), Texas (Austin, Houston), and Washington (Seattle, Tacoma, Wenatchee), supplemented by virtual appointments. The practice is HIPAA-compliant, LegitScript-verified, and operates on a NextGen-powered patient portal.

The company is privately held with no disclosed parent company or institutional investors beyond a single $5,420,648 funding round in October 2017, and is led by co-founder and board member Ara Chackerian alongside Chief Medical Officer Richard Bermudes. It positions itself within an addressable market where 1 in 3 people with depression are treatment-resistant to traditional antidepressants, focusing on the subset of psychiatric patients who have not responded to standard pharmacotherapy.

Short descriptiontext

TMS Health Solutions (DBA Mindful Health Solutions) is a private interventional psychiatry provider operating 20 clinics across California, Texas, and Washington, delivering FDA-cleared TMS, SPRAVATO, and Ketamine treatments to patients with treatment-resistant depression and other mood and anxiety disorders.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices20 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
interventional psychiatry, treatment-resistant depression, transcranial magnetic stimulation, behavioral health services, psychiatric medication management
Industry1 code
1Psychiatry & Medication Management Platforms
CodeHLALAEABPrimaryYes
NAICS code2 codes
  • Offices of Physicians, Mental Health Specialists621112
  • Outpatient Mental Health and Substance Abuse Centers621420
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Interventional Psychiatry / Mental Health Treatment Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Treatment Sessions and Medication Management
TypeSubscription Recurring
Description

The company generates revenue through recurring treatment sessions and ongoing medication management. Patients receive multiple treatment sessions over time for TMS (typically 4-6 weeks of daily sessions), SPRAVATO (twice weekly for 4 weeks, then regular maintenance), and Ketamine Infusion Therapy (series of infusions followed by maintenance). Additional revenue from medication management and telehealth appointments.

mindfulhealthsolutions.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Insurance-based treatment with self-pay options for uninsured services
ModelOtherBilling cadencePer session or treatment series
Notes

Quote-based pricing not publicly disclosed; accepts major insurance plans

mindfulhealthsolutions.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Mindful Health Solutions (d/b/a TMS Health Solutions) is a behavioral health care provider that delivers interventional psychiatric treatments for treatment-resistant depression, major depressive disorder, and mood/anxiety disorders. Core offerings include Transcranial Magnetic Stimulation (TMS), the MindfulONE One-Day TMS protocol, Accelerated TMS, SPRAVATO (Esketamine) nasal spray therapy, Ketamine Infusion Therapy, psychiatric medication management, and telepsychiatry. Services are delivered through 20 physical clinics and telehealth across California, Texas, and Washington.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 80% of patients experience symptom improvement following treatment at Mindful Health Solutions
+3 more records
Product overview1 text field

Mindful Health Solutions is a behavioral health care provider offering a portfolio of interventional psychiatric treatments for treatment-resistant depression, major depressive disorder, and other mood and anxiety disorders. The company operates as a single unified healthcare practice with multiple treatment modalities including TMS Therapy (including MindfulONE one-day protocol and Accelerated TMS), SPRAVATO (Esketamine) nasal spray, and Ketamine Infusion Therapy. These are complemented by medication management and telehealth services. The treatments target conditions including Major Depressive Disorder, Generalized Anxiety Disorder, Obsessive-Compulsive Disorder, Bipolar Disorder, PTSD, and ADHD.

Product and service1 record
1TMS Therapy
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the largest U.S. networks of TMS treatment centers, operating 100+ clinics. Direct competitor in the interventional psychiatry / TMS clinic category, serving the same treatment-resistant depression and mood disorder patient base.

TypeDirect peer
Description

Multi-location TMS clinic operator serving treatment-resistant depression patients. Overlapping service mix and patient profile make it a closely comparable outpatient interventional psychiatry peer.

TypeDirect peer
Description

Multi-clinic specialty psychiatry practice using imaging and innovative treatment protocols. Comparable as a destination, multi-location behavioral health practice differentiated by proprietary methodology rather than general outpatient therapy.

TypeBroad incumbent
Description

Manufacturer of the NeuroStar TMS system, which is the device platform underlying much of the TMS market. Comparable as the upstream technology incumbent whose product enables the company's TMS service line.

TypeBroad incumbent
Description

Manufacturer of Deep TMS systems used in depression and OCD treatment. Broad incumbent and enabling technology peer for any TMS-clinic operator.

TypeRegional player
Description

Louisiana-based specialty psychiatric care provider. Operates in a different geographic footprint but is comparable as a specialty psychiatric services provider focused on complex behavioral health cases.

TypeEmerging player
Description

Virtual and intensive outpatient mental health provider targeting teens, young adults, and families with complex depression and anxiety. Comparable as an emerging, technology-enabled behavioral health provider competing for the same referral pathways.

TypeEmerging player
Description

Digital mental health platform offering medication management and counseling. Comparable as a telehealth-enabled behavioral health peer targeting patients seeking treatment for depression and anxiety, though Cerebral focuses on pharmaceuticals rather than interventional procedures.

TypeEmerging player
Description

Telehealth psychiatry and therapy provider with a focus on anxiety and depression outcomes. Comparable as a tech-enabled emerging player competing for telepsychiatry and medication management patients in the same therapeutic category.

TypeEmerging player
Description

Clinical-stage psychedelics company developing psilocybin treatment for treatment-resistant depression. Adjacent/emerging peer as a future-treatment modality competitor to TMS, SPRAVATO, and ketamine for the same patient population.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TMS Health Solutions

Interventional Psychiatry / Mental Health Treatment Servicestmshealthsolutions.com

TMS Health Solutions (DBA Mindful Health Solutions) is a private interventional psychiatry provider operating 20 clinics across California, Texas, and Washington, delivering FDA-cleared TMS, SPRAVATO, and Ketamine treatments to patients with treatment-resistant depression and other mood and anxiety disorders.

What TMS Health Solutions does

TMS Health Solutions, operating under the DBA Mindful Health Solutions, is a private interventional psychiatry provider founded in 2007 and headquartered in San Francisco. The company delivers FDA-cleared, device- and medication-based treatments for treatment-resistant depression and other mood and anxiety disorders, with a portfolio comprising Transcranial Magnetic Stimulation (TMS, including standard, Accelerated, and the MindfulONE One-Day protocols), SPRAVATO (Esketamine) nasal spray therapy, Ketamine Infusion Therapy, psychiatric medication management, and California-based telepsychiatry. Reported clinical efficacy figures include approximately 63% effectiveness for TMS, 70% for SPRAVATO, 49% for Ketamine, and an overall 80% symptom-improvement rate across treated patients, with 100,000+ patients and 300,000+ interventional treatments administered cumulatively.

The company monetizes through recurring per-session and per-treatment-course billing under major commercial insurance plans, with self-pay options for uninsured services. Patient acquisition runs through a sales-led GTM combining direct-to-consumer channels (content marketing, social media on Facebook, Instagram, TikTok, YouTube, and LinkedIn, plus online insurance verification and self-scheduling tools), a healthcare provider referral program, and a 20-clinic physical footprint across California (15 clinics in the Sacramento, Bay Area, and Southern California regions), Texas (Austin, Houston), and Washington (Seattle, Tacoma, Wenatchee), supplemented by virtual appointments. The practice is HIPAA-compliant, LegitScript-verified, and operates on a NextGen-powered patient portal.

The company is privately held with no disclosed parent company or institutional investors beyond a single $5,420,648 funding round in October 2017, and is led by co-founder and board member Ara Chackerian alongside Chief Medical Officer Richard Bermudes. It positions itself within an addressable market where 1 in 3 people with depression are treatment-resistant to traditional antidepressants, focusing on the subset of psychiatric patients who have not responded to standard pharmacotherapy.

TMS Health Solutions firmographics

Firmographics
Name
TMS Health Solutions
Legal name
Mindful Health Solutions
Website
https://tmshealthsolutions.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
101–250 employees
Short description
TMS Health Solutions (DBA Mindful Health Solutions) is a private interventional psychiatry provider operating 20 clinics across California, Texas, and Washington, delivering FDA-cleared TMS, SPRAVATO, and Ketamine treatments to patients with treatment-resistant depression and other mood and anxiety disorders.
Ownership category
akta.pro rank

TMS Health Solutions industry classification

Industry
Product category
Interventional Psychiatry / Mental Health Treatment Services
NAICS
Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro primary industry
Psychiatry & Medication Management Platforms (HLALAEAB)

Keywords

  • Interventional psychiatry
  • Treatment-resistant depression
  • Transcranial magnetic stimulation
  • Behavioral health services
  • Psychiatric medication management

Where TMS Health Solutions is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices20 records

Markets served

TMS Health Solutions business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Treatment Sessions and Medication Management: The company generates revenue through recurring treatment sessions and ongoing medication management. Patients receive multiple treatment sessions over time for TMS (typically 4-6 weeks of daily sessions), SPRAVATO (twice weekly for 4 weeks, then regular maintenance), and Ketamine Infusion Therapy (series of infusions followed by maintenance). Additional revenue from medication management and telehealth appointments.

Pricing tiers

ModelBillingPrice
OtherPer session or treatment seriesInsurance-based treatment with self-pay options for uninsured services

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

TMS Health Solutions product offering

Product offering

Core offering

Mindful Health Solutions (d/b/a TMS Health Solutions) is a behavioral health care provider that delivers interventional psychiatric treatments for treatment-resistant depression, major depressive disorder, and mood/anxiety disorders. Core offerings include Transcranial Magnetic Stimulation (TMS), the MindfulONE One-Day TMS protocol, Accelerated TMS, SPRAVATO (Esketamine) nasal spray therapy, Ketamine Infusion Therapy, psychiatric medication management, and telepsychiatry. Services are delivered through 20 physical clinics and telehealth across California, Texas, and Washington.

Product overview

Mindful Health Solutions is a behavioral health care provider offering a portfolio of interventional psychiatric treatments for treatment-resistant depression, major depressive disorder, and other mood and anxiety disorders. The company operates as a single unified healthcare practice with multiple treatment modalities including TMS Therapy (including MindfulONE one-day protocol and Accelerated TMS), SPRAVATO (Esketamine) nasal spray, and Ketamine Infusion Therapy. These are complemented by medication management and telehealth services. The treatments target conditions including Major Depressive Disorder, Generalized Anxiety Disorder, Obsessive-Compulsive Disorder, Bipolar Disorder, PTSD, and ADHD.

Differentiator

Problem solved

Functional benefit

Products and services

  • TMS Therapy

Quantifiable outcome

  • 80% of patients experience symptom improvement following treatment at Mindful Health Solutions
  • +3 more outcomes

Companies that use TMS Health Solutions

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles2 records

TMS Health Solutions technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

TMS Health Solutions partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

TMS Health Solutions competitors and assessment

Company assessment

Direct peers

  • Greenbrook TMS NeuroHealth Centers: One of the largest U.S. networks of TMS treatment centers, operating 100+ clinics. Direct competitor in the interventional psychiatry / TMS clinic category, serving the same treatment-resistant depression and mood disorder patient base.
  • Success TMS: Multi-location TMS clinic operator serving treatment-resistant depression patients. Overlapping service mix and patient profile make it a closely comparable outpatient interventional psychiatry peer.
  • Amen Clinics: Multi-clinic specialty psychiatry practice using imaging and innovative treatment protocols. Comparable as a destination, multi-location behavioral health practice differentiated by proprietary methodology rather than general outpatient therapy.

Broad incumbents

  • Neuronetics: Manufacturer of the NeuroStar TMS system, which is the device platform underlying much of the TMS market. Comparable as the upstream technology incumbent whose product enables the company's TMS service line.
  • BrainsWay: Manufacturer of Deep TMS systems used in depression and OCD treatment. Broad incumbent and enabling technology peer for any TMS-clinic operator.

Regional players

  • Apollo Behavioral Health Hospital: Louisiana-based specialty psychiatric care provider. Operates in a different geographic footprint but is comparable as a specialty psychiatric services provider focused on complex behavioral health cases.

Emerging players

  • Charlie Health: Virtual and intensive outpatient mental health provider targeting teens, young adults, and families with complex depression and anxiety. Comparable as an emerging, technology-enabled behavioral health provider competing for the same referral pathways.
  • Cerebral: Digital mental health platform offering medication management and counseling. Comparable as a telehealth-enabled behavioral health peer targeting patients seeking treatment for depression and anxiety, though Cerebral focuses on pharmaceuticals rather than interventional procedures.
  • Brightside Health: Telehealth psychiatry and therapy provider with a focus on anxiety and depression outcomes. Comparable as a tech-enabled emerging player competing for telepsychiatry and medication management patients in the same therapeutic category.
  • Compass Pathways: Clinical-stage psychedelics company developing psilocybin treatment for treatment-resistant depression. Adjacent/emerging peer as a future-treatment modality competitor to TMS, SPRAVATO, and ketamine for the same patient population.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

TMS Health Solutions social profiles

Digital presence

TMS Health Solutions compliance and trust

Trust signal

Compliance2 records

TMS Health Solutions financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TMS Health Solutions leadership team

Management profile

Number of profiles

Profiles2 records

TMS Health Solutions funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TMS Health Solutions M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TMS Health Solutions

What does TMS Health Solutions do?

Mindful Health Solutions (d/b/a TMS Health Solutions) is a behavioral health care provider that delivers interventional psychiatric treatments for treatment-resistant depression, major depressive disorder, and mood/anxiety disorders. Core offerings include Transcranial Magnetic Stimulation (TMS), the MindfulONE One-Day TMS protocol, Accelerated TMS, SPRAVATO (Esketamine) nasal spray therapy, Ketamine Infusion Therapy, psychiatric medication management, and telepsychiatry. Services are delivered through 20 physical clinics and telehealth across California, Texas, and Washington.

Is TMS Health Solutions a public or private company?

TMS Health Solutions is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was TMS Health Solutions founded?

TMS Health Solutions was founded in 2007. It employs 101 to 250 people.

Where is TMS Health Solutions based?

TMS Health Solutions is headquartered in San Francisco, United States, in the North America region.

How does TMS Health Solutions make money?

One revenue line is on record: treatment Sessions and Medication Management.

Who are TMS Health Solutions's main competitors?

Direct peers on record are Greenbrook TMS NeuroHealth Centers, Success TMS and Amen Clinics. Broad incumbents are Neuronetics and BrainsWay. Apollo Behavioral Health Hospital is listed as a regional player. Emerging players are Charlie Health, Cerebral, Brightside Health and Compass Pathways.

Does TMS Health Solutions have an API?

No public API is recorded for TMS Health Solutions.

What industry is TMS Health Solutions in?

TMS Health Solutions's product category is Interventional Psychiatry / Mental Health Treatment Services. Its primary akta.pro industry code is HLALAEAB, Psychiatry & Medication Management Platforms. Its NAICS code is 621112 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals